Statements (55)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:healthcare_organization
|
gptkbp:affiliatedWith |
gptkb:Erasmus_University
|
gptkbp:collaboratesWith |
International_Research_Institutions
|
gptkbp:conducts |
Translational Research
|
gptkbp:focusesOn |
gptkb:Cancer_Research
|
gptkbp:hasCollaborationsWith |
Government Agencies
Academic Institutions Pharmaceutical Companies Biotechnology Firms Non-Profit_Organizations |
gptkbp:hasLocalCuisine |
Personalized Medicine
Gene Therapy Targeted Therapies Combination Therapies New Cancer Drugs |
gptkbp:hasPrograms |
Fellowships
Continuing Medical Education Support Groups Nutritional Counseling Residency Programs Psychosocial Support Survivorship Programs Rehabilitation_Services |
gptkbp:hasPublications |
Medical Journals
Research Conferences Clinical_Trials_Registries |
gptkbp:hasResearchFocus |
gptkb:Melanoma
gptkb:Lung_Cancer Cancer Prevention Leukemia Colorectal Cancer Lymphoma Prostate Cancer Breast Cancer Cancer Epidemiology Cancer_Genetics Cancer_Immunology Cancer_Treatment_Innovations |
gptkbp:hasSpecialty |
Radiation Oncology
Medical Oncology Surgical Oncology |
https://www.w3.org/2000/01/rdf-schema#label |
Erasmus MC Oncology
|
gptkbp:isRecognizedFor |
Innovative Cancer Treatments
High-Quality Patient Care Cutting-Edge_Research |
gptkbp:locatedIn |
gptkb:Rotterdam
|
gptkbp:offers |
Clinical Trials
|
gptkbp:offersServices |
gptkb:Chemotherapy
Palliative Care Immunotherapy |
gptkbp:partOf |
gptkb:Erasmus_MC
|
gptkbp:provides |
Patient_Care
|
gptkbp:receivesFundingFrom |
Research Grants
Corporate Sponsorships Philanthropic Donations |